Stuff From The Annual Report6 May 2020 12:50
The full annual report is on the website. When I looked it was erroneously labeled as an interim report in the Results Centre section.
A few things:
Bellascura - suggests US insurance companies will like X-P02R as it's 70% cheaper over the COPD treatment period than competitors. Cost is a big thing to private US health insurers and especially Medicare which has cut the payment to companies which provide a complete COPD service ( renting and support of oxygen concentrators). Difficult to see how these insurers wouldn't push for X-PL02R over competitor products that have to be replaced as the disease progresses.
Guident - The team's building. My guess is Guident is having initial early transaction and so quality people are happy to join. Florida has mandated Guident type support. Which means, practically, all of the US has mandated it. You couldn't sell a car in Texas which could never be driven into Florida. Which also means global car companies would buy Guident software so their cars, even if sold outside the US, could be resold second hand into the US.
Salarius - Microsalt sales to 3 snack companies so far. 25 others trialling. SaltMe to begin sales this quarter. Just guessing but maybe sales to big supermarket chains in H2. Albertson's, the second largest US supermarket ($62bn sales) has a former Director of Product Development on the Salarius board.
Crazy cheap at this price. Any one portfolio company could be worth 10 times the current market cap by year end. And all IP protected.